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e Max Planck Institute for Medical Research, Jahnstraße 29, Heidelberg, 69120, Germany 
f Institute for Physical Chemistry, Heidelberg University, INF 253, Heidelberg, 69120, Germany   







Adoptive cell therapy 
A B S T R A C T   
Recent achievements in the field of immunotherapy, such as the development of engineered T cells used in 
adoptive cell therapy, are introducing more efficient strategies to combat cancer. Nevertheless, there are still 
many limitations. For example, these T cells are challenging to manufacture, manipulate, and control. Specif-
ically, there are limitations in producing the large amounts of therapeutic T cells needed for these therapies in a 
short period of time and in an economically viable manner. In this study, three-dimensional (3D) poly(ethylene) 
glycol (PEG) hydrogels covalently combined with low molecular weight heparin are engineered to resemble the 
lymph nodes, where T cells reproduce. In these hydrogels, PEG provides the needed structural and mechanical 
properties, whereas heparin is used as an anchor for the cytokine CCL21, which is present in the lymph nodes, 
and can affect cell migration and proliferation. The 3D structure of the hydrogel in combination with its loading 
capacity result in an increased primary human CD4+ T cell proliferation compared to the state-of-the-art 
expansion systems consisting of artificial antigen presenting cells. Thus, we present a new tool for adoptive 
cell therapy to help achieving the large numbers of cells required for therapy of selected phenotypes targeted 
against cancer cells, by mimicking the lymph nodes.   
1. Introduction 
Immunotherapy is a medical strategy that offers an approach 
different from chemotherapy, radiation, and surgery in the treatment of 
cancer, which is based on harnessing the immune system of patients. The 
immune system protects the organism against disease, distinguishing 
between self and non-self. Nevertheless, cancer appears from the own 
cells of an organism, and it creates a tumor microenvironment with 
immune evasion and immunosuppression signals capable of avoiding 
the immune response [1]. Fortunately, T cells can be genetically modi-
fied by engineering their T cell receptors (TCRs) or making them express 
chimeric antigen receptors (CARs) to recognize and eliminate malignant 
cells more effectively [2]. These cells have been used in adoptive cell 
therapy (ACT), resulting in some encouraging achievements [3]. Indeed, 
the use of living cells as therapeutic agents is radically different from 
other available systems such as small molecules or antibodies due to the 
capacity of cells to sense and develop different responses depending on 
the stimulus that they are exposed to. Nonetheless, this therapy is 
technically challenging [4], i.e. modified T cells are difficult to manu-
facture, manipulate, and control [5]. Specifically, the efficiency of the ex 
vivo expansion process of these functional T cells to achieve relevant 
clinical doses is a major limiting factor to translate the therapy to clinics 
[2]. Additionally, ACT based on tumor infiltrating lymphocytes (TILs) 
[6,7], which are T cells that infiltrate a tumor and are selective for it, 
would also benefit from efficient expansion systems, due to their low 
prevalence [8]. 
Although different approaches have been proposed [9,10], including 
materials with control at the nanoscale [11–15], ex vivo T cell expan-
sions are usually performed in suspension using artificial antigen pre-
senting cells (APCs), such as Dynabeads® (Thermo Fisher Scientific, 
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USA). These artificial beads are 4.5 μm superparamagnetic spheres 
decorated with the antibodies antiCD3 and antiCD28, which poly-
clonally activate T cells through the TCR complex and the costimulating 
receptor CD28 [16–19], thus mimicking the natural immunological 
synapse. However, the secondary lymphoid organs (SLOs), especially 
the lymph nodes (LNs), where the interaction between these cells occurs 
in our body, are not considered despite the growing evidence of their 
influence [20–22]. For example, the LNs provide homing signals 
through the cytokine CCL21, which is immobilized in the lymphoid 
tissues through its extended C terminus that reversibly binds to glycos-
aminoglycan components of the extracellular matrix (ECM), namely 
heparan sulfate [23,24]. CCL21 interacts with naïve T cells and APCs, 
through the chemokine receptor CCR7, enhancing CD4+ and CD8+ T cell 
proliferation and promoting random migration [25,26]. 
Hydrogels are three-dimensional (3D) natural or synthetic structures 
that are often used as a tool to mimic the ECM with the objective to 
recreate the natural environment of cells [27–29]. These systems offer 
more realistic conditions than hard planar substrates such as standard 
polystyrene dishes, improving the standard cell culture techniques [30]. 
They can also be used to put cells in contact with different proteins and 
growth factors, which can influence different cellular responses, such as 
differentiation or growth [31]. Poly(ethylene glycol) (PEG) hydrogels 
have been extensively studied because of their interesting physico-
chemical properties, such as their tunable stiffness, which can be varied 
over six orders of magnitude [32]. These hydrogels are biologically inert 
due to their hydrophilic character, which prevents unspecific attach-
ment to proteins, but they have shown to successfully encapsulate cells 
with maintained cell viability, even without integrin-binding ligands 
[33,34]. Nevertheless, they can be easily engineered to present different 
functionalities such as cell adhesive motifs [35–37]. Moreover, they can 
be manufactured under mild and cytocompatible conditions with high 
reproducibility [38,39]. 
Heparin is a common anticoagulant used to prevent the formation of 
blood clots as well as to treat venous thromboembolisms and myocardial 
infarction, based on its capacity to interact with positively charged 
binding sites of proteins [40]. Indeed, heparin can be neutralized in case 
of an adverse clinical effect with protamine, a small protein rich in the 
positively charged amino acid arginine at physiological pH [41]. The 
anionic charge of heparin has also been exploited to improve its ab-
sorption with positively charged polyethylenimines [42]. In fact, hep-
arin is described as a more sulfated variant of heparan, which can bind to 
different proteins such as CCL21, through its anionic character as well as 
sequence specificity in some cases [31,43]. Low molecular weight 
heparin (LMWH) offers some advantages over unfractionated heparin 
(UFH) in clinical settings such as a subcutaneous delivery, reduced risk 
of hemorrhage, longer half-life, greater bioavailability, and more pre-
dictable pharmacokinetics [44]. Moreover, its smaller size and lower 
polydispersity compared to UFH [45,46], promote hydrogel reproduc-
ibility, as previously shown for PEG-LMWH hydrogels [47,48]. 
Here we describe a family of 3D hydrogels consisting of PEG and 
LMWH (PEG-Hep hydrogels) loaded with CCL21 that were synthesized 
and fully characterized in order to imitate the conditions of the ECM of 
the LNs with the objective to increase primary human (CD4+) T cell 
proliferation and tune differentiation for ACT (Fig. 1). 
CD4+ T cell proliferation was enhanced when using these 3D struc-
tures in combination to the artificial APCs Dynabeads, thus improving 
the state-of-the-art suspension systems. Additionally, the phenotypes 
obtained – naïve (TN), central memory (TCM), and effector memory 
(TEM) – were studied given their clinical importance. 
2. Results and discussion 
2.1. Synthesis and characterization of PEG-Hep hydrogels 
In this section, the synthesis of PEG-Hep hydrogels is provided, 
which is based on previous reports [47,48]. Moreover, we describe the 
capacity of these hydrogels to be loaded with proteins through the 
heparin unit, mostly through electrostatic interactions, as it has been 
shown for other systems [49]. Indeed, the protein repellent character of 
PEG prevents unspecific interactions, thus resulting in well-defined 
Fig. 1. T cell expansion in a CCL21-loaded PEG-Hep hydrogel as part of an ACT process. Simplified scheme of an ACT process (e.g. without including the genetic 
modification of the cells or the selection of TILs) with T cells cultured in the CCL21-loaded PEG-Hep hydrogels (not to scale). In our protocol, human primary CD4+ T 
cells from adult healthy donors were activated with the artificial APCs Dynabeads and used as a proof-of-concept prior to testing with patients. Thus, the expanded T 
cells were not reinfused. 
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hydrogels whose chemical stimuli are conveyed through the heparin 
loading. Additionally, a full characterization of the structural, me-
chanical, and chemical properties of the PEG-Hep hydrogels is included, 
which is focused on identifying and obtaining the most suitable hydro-
gels to mimic the LNs. 
2.1.1. Synthesis of Mal-LMWH and PEG-Hep hydrogel formation 
A Michael-type reaction was used to functionalize LMWH with a 
maleimide group yielding a Mal-LMWH derivative (Fig. S1) [48]. The 
process was left overnight and the final product was purified by dialysis. 
The success of the reaction was assessed by proton nuclear magnetic 
resonance (1H NMR) through the carbon double bond maleimide peak at 
6.83 ppm, as well as attenuated total reflection (ATR) spectroscopy with 
the two bands at 1709 and 1564 cm− 1 associated to the carbonyl groups 
and the carbon double bond of the maleimide ring, respectively 
(Fig. S2). PEG-Hep hydrogels were formed through a maleimide-thiol 
reaction between the Mal-LMWH derivative and a 4-arm thiolated 
PEG (PEG-SH) in phosphate buffered saline (PBS), resulting in a covalent 
crosslink and the consequent gelation (Fig. 2A). Conversely, mixtures of 
non-functionalized LMWH and PEG-SH did not result in hydrogel for-
mation (Fig. S3). 
Hydrogels with different weight percentages of PEG (6%wt, 4%wt, 
and 3%wt) were formed, while using the same ratio of PEG-SH and Mal- 
LMWH (1:1.5). The gelation process and mechanical properties of these 
Fig. 2. PEG-Hep hydrogel formation. A) Scheme of the PEG-Hep hydrogel formation, B) time sweeps of 6%wt, 4%wt, and 3%wt PEG-Hep hydrogels and C) lateral- 
(left) and top-view (right) images of a 6%wt PEG-Hep hydrogel. 
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hydrogels were characterized by small-amplitude oscillatory shear 
(SAOS) rheology. The protocol followed was a cycle of sweeps, i.e. time 
sweep, strain sweep, and frequency sweep, followed by a second time 
sweep [50]. The final time sweeps were performed at 50 Pa and 0.1 Hz 
with the rheometer at 37◦C (Fig. 2B). The 6%wt PEG-Hep hydrogels 
were stabilized after ca. 200 min, while the 3%wt PEG-Hep hydrogels 
required 240 min. All hydrogels were stable for over 48 h in the incu-
bator with cell culture medium (Fig. 2C). 
2.1.2. Structural properties of PEG-Hep hydrogels 
The three different types of PEG-Hep hydrogels were studied by 
scanning electron microscopy (SEM) and their pore size ranges were 
calculated (Fig. 3A). 
The median pore size of the 6%wt PEG-Hep hydrogels is 20 μm with 
a porosity range of 5–50 μm, which increases to 40 μm for the 4%wt 
hydrogels with a range of 20–75 μm, and to 55 μm with a range of 
25–105 μm for the 3%wt PEG-Hep hydrogels. Thus, the lower the 
amount of PEG, the higher the porosity of the hydrogel, as expected. 
Pore sizes of 80 μm were described to result in unconstrained migration, 
similar to the one observed in collagen, the major ECM protein of the 
LNs, unlike smaller pore sizes (20–40 μm) [51]. We hypothesize that the 
median pore size of ca. 55 μm that we obtained might be even more 
adequate than larger pore sizes for T cell activation, as it might intro-
duce minimal constrains to ensure the formation of the immunological 
synapse between T cells and the artificial APCs Dynabeads, which has 
been described to occur in periods of time ranging from a few minutes up 
to 2 days for CD4+ T cells [52–54]. Moreover, it is known that T cells 
aggregate together with Dynabeads when they proliferate resulting in 
clusters [12,55,56]. Thus, the 3%wt hydrogels are also more suitable 
than the 4%wt and 6%wt ones to allow such aggregates. Additionally, 
3%wt PEG-Hep hydrogels were freeze-dried and their 3D structure was 
characterized by X-ray microtomography. Thus, the internal structure of 
the hydrogels could be observed, revealing pore interconnectivity, in 
agreement with the SEM images (Fig. 3B). Although we cannot entirely 
discard an increase in interconnectivity caused by the effect of the 
freeze-drying process, primary human CD4+ T cell infiltration in 3%wt 
PEG-Hep hydrogels was demonstrated by confocal microscopy over 
large areas, using hydrogels that were not submitted to such process 
(Figs. 3C and S4). To visualize the cells inside the hydrogels, they were 
stained with carboxyfluorescein diacetate succinimidyl ester (CFSE), an 
intracellular dye that is only fluorescent in viable cells. Finally, the 
swelling ratio of the 3%wt PEG-Hep hydrogels in PBS was determined to 
be 18.5 ± 1.2 [57]. 
2.1.3. Chemical properties: loading capacity of the PEG-Hep hydrogels 
PEG-Hep hydrogels are expected to be a well-defined platform whose 
chemical stimuli are specifically provided by interactions with the 
negatively charged heparin units, given the inert character of PEG. 
Indeed, the capacity of heparin (UFH and LMWH) to electrostatically 
interact with positive binding sites of proteins is the basis for its 
Fig. 3. Structural properties of PEG-Hep hydrogels. A) SEM images and pore size evaluation of PEG-Hep hydrogels with different compositions of PEG (6%wt, 4% 
wt, and 3%wt). The statistical significance was determined by the Kruskal Wallis ANOVA test (***p < 0.001). B) X-ray microtomographs of a 3%wt PEG-Hep 
hydrogel of 1 cm of diameter (top-left image) and a small homogeneous zone (3.5 mm of diameter and 500 μm of height) used to analyze its porosity (bottom- 
right image). C) Confocal maximum projection showing CFSE-stained primary human CD4+ T cells in 3%wt PEG-Hep hydrogels after 5 days of incubation (scale bar 
= 20 μm). 
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application as anticoagulant and protein stabilizer, as mentioned before 
[40]. The estimated charge of UFH is approximately − 75, which has 
been calculated considering that on average, there are 2.7 sulfate groups 
per disaccharide monomer, the repeating units of heparin consisting of 
uronic acid and glucosamine in a 1,4-linkage, and heparin has an 
averaged molecular weight of 15 kDa [40,58,59]. Considering that the 
LMWH here used is reported to have an averaged molecular weight of 5 
kDa according to the provider, an estimated charge of ca. − 25 is 
expected. 
To corroborate the electrostatic interaction between LMWH and 
positively charged units, LMWH was incubated with a model protein 
consisting of a modified green fluorescent protein (mGFP), which has an 
estimated charge of +5.6 (see supplementary data). The resulting 
mixture was analyzed by dynamic light scattering (DLS) and zeta po-
tential measurements. In the DLS, solutions of LMWH and mGFP showed 
single peaks at 0.7 ± 0.1 nm and 4.6 ± 0.4 nm, respectively. In contrast, 
the measurements of the mixture of LMWH and mGFP resulted in a main 
peak at 5.4 ± 0.4 nm, which is larger than any of the reactants alone, 
thus suggesting that there is interaction between them (Fig. 4A). Addi-
tionally, there is a broad band around 25 nm in the mGFP that also grows 
in percentage when the Mal-LMWH is present. 
The zeta potential measurements were performed in PBS, which 
Fig. 4. Chemical and mechanical properties of PEG-Hep hydrogels. A) DLS and B) zeta potential of Mal-LMWH, mGFP, and a mixture of both. C) Loading curve 
of 6%wt, 4%wt, and 3%wt PEG-Hep hydrogels with mGFP. D) Strain sweeps and E) frequency sweeps of 6%wt, 4%wt, and 3%wt PEG-Hep hydrogels. 
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showed a value of − 13.0 mV. The LMWH and mGFP exhibited values of 
− 31.4 mV and − 8.3 mV, respectively, whereas the mixture was almost 
neutralized with a value of − 11.1 mV, similar to PBS (Fig. 4B). Thus, 
these results support the reported evidence on the capacity of heparin to 
interact with positively charged units. 
Finally, PEG-Hep hydrogels were also incubated with the mGFP 
during 1 h. After proper rinsing with PBS, the resulting fluorescence of 
the hydrogels was measured (Fig. 4C). The 3%wt PEG-Hep hydrogel 
shows a higher retention capacity than the 4%wt and the 6%wt PEG-Hep 
hydrogels, suggesting that it has a better pore interconnectivity that 
allows the mGFP solution to easily diffuse into the hydrogel. 
2.1.4. Mechanical properties of PEG-Hep hydrogels 
Fully formed PEG-Hep hydrogels were characterized by rheometry. 
Strain sweeps were performed at a constant frequency of 1.0 Hz and the 
pressure was swept from 1 Pa to 150 Pa on the fully formed gel (Fig. 4D). 
Then frequency sweeps were performed from 0.01 Hz to 10 Hz at a 
constant strength of 50 Pa (Fig. 4E). 
All hydrogels exhibited linear behavior of dynamic modulus (G′) 
from a strength of 10 Pa–100 Pa. The 3%wt PEG-Hep hydrogels showed 
a G′ lower than those of 4%wt and 6%wt. The frequency sweeps were 
linear from 0.01 Hz to 1 Hz. Similarly, lower G’ values were obtained for 
the 3%wt than the 4%wt and 6%wt PEG-Hep hydrogels. The values of 
the equilibrium shear modulus (Ge) achieved were 4.8 ± 0.2 KPa for the 
6%wt PEG-Hep hydrogels, 3.1 ± 0.1 KPa in the case of the 4%wt PEG- 
Hep hydrogels, and 1.1 ± 0.1 KPa for the 3%wt PEG-Hep hydrogels. 
Thus, hydrogels with less PEG and heparin are softer than those with 
higher amounts of material, as expected. However, the values obtained 
are very similar and all in agreement with the reported LN stiffness, 
which is around 10 KPa as measured by in vivo shear-wave elastography 
[60–63]. 
2.2. T cell expansion and differentiation using 3D PEG-Hep hydrogels 
After the synthesis and physicochemical characterization of the 
hydrogels, 3 wt% PEG-Hep hydrogels were chosen to culture T cells 
given their largest pore size and highest interconnectivity, while keeping 
adequate mechanical properties. To perform these experiments, primary 
human CD4+ T cells of healthy adult donors were used as a relevant 
population in the clinics [64–69], but also due to their highest natural 
occurrence in peripheral blood in comparison to other populations of 
clinical interest such as CD8+ or regulatory T cells. T cell proliferation 
and differentiation were measured on days 5–6 as a standard prolifer-
ation time point that allows to assess the success of the (loaded) 3D 
structures [55,70]. The effect of immobilizing CCL21 compared to 
having it in solution on CD4+ T cell cultures was first confirmed using 
planar surfaces to reduce the complexity of the system given by the 3D 
structure. Additionally, these experiments allowed us to establish an 
initial concentration range to load the hydrogels. 
Fig. 5. Effect of CCL21 immobilization on CD4+ T cell expansion. Normalized proliferation analysis of CD4+ T cells 6 days after seeding with Dynabeads and 
different concentrations of CCL21 A) in suspension (Ndonors = 5, with a minimum of Ndonors/condition = 4) and B) fixed to Au surfaces (Ndonors = 8). The replication 
index (fold-expansion of the responding cells), expansion index (fold-expansion of the overall culture), and proliferation index (average number of divisions among 
the responding cells) were measured. Statistical significance was determined by the Mann-Whitney U test (**p < 0.01). 
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2.2.1. Effect of CCL21 immobilization on CD4+ T cell expansion 
CCL21 is a cytokine with an estimated charge of +17.0 that cos-
timulates the expansion of CD4+ T cells and is immobilized in the LNs 
through heparan, as mentioned before. Prior to loading CCL21 to the 
hydrogel, the effect of its immobilization was studied. With this objec-
tive, different concentrations of CCL21 were seeded in suspension and 
fixed on planar gold (Au) surfaces through its cysteine groups, given the 
well-known anchoring capacity of Au through the formation of covalent 
thiol-Au bonds (Fig. S5) [71]. The concentrations chosen were 1 ng/ml, 
20 ng/ml, and 100 ng/ml for experiments in suspension as well as 1 
ng/ml and 20 ng/ml for the CCL21-immobilized surfaces (Figs. 5 and 
S6). Elevated concentrations of CCL21 were avoided given their 
potentially inhibitory effect [72]. 
Thus, CD4+ T cell proliferation was evaluated by flow cytometry 
through CFSE stainings. Specifically, the expansion, replication, and 
proliferation indexes were calculated with the software FlowJo (see 
Fig. 6. Effect of 3D PEG-Hep hydrogels on CD4þ T cell proliferation. A) Representative flow cytometry histograms of the B) propidium iodide (PI) viability test 
performed to CD4+ T cells seeded on 3 wt% PEG-Hep hydrogels. Bars are mean + standard deviation (Ndonors = 3). C) Representative CFSE diagram of D) normalized 
replication, expansion, and proliferation indexes of CD4+ T cells stimulated with Dynabeads 5 days after seeding in unloaded 3 wt% PEG-Hep hydrogels (Ndonors = 6). 
Statistical significance was determined by the Mann-Whitney U test (*p < 0.05, **p < 0.01). 
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supplementary data) [73]. The expansion and replication indexes 
determine the fold-expansion of the overall culture and that of the 
responding cells, respectively. The proliferation index is the average 
number of divisions that all responding cells have undergone since the 
beginning of the culture. These three parameters are therefore relevant 
for cell therapy, showing how responsive the cells are to the proliferative 
stimulus and how many cells can be obtained. 
To minimize the variability caused by the different donors, the re-
sults obtained were normalized relative to the positive controls (CD4+ T 
cells stimulated in suspension with Dynabeads) of each independent 
experiment. Thus, the value of all indexes for the positive control is 1. 
The negative controls correspond to CD4+ T cells seeded in suspension 
without Dynabead stimulation. 
As shown above, no significant differences could be observed among 
the different CCL21 concentrations in suspension (Figs. 5A and S6A). 
The median values for the replication index for 100 ng/ml, 20 ng/ml, 
and 1 ng/ml were 1.01, 0.95, and 0.96, respectively, i.e. very close to the 
positive controls. The same tendency was observed for the expansion 
index, with median values of 0.99, 1.02, and 0.99, and the proliferation 
index with values of 1.05, 1.12, and 1.00 for 100 ng/ml, 20 ng/ml, and 1 
ng/ml, respectively. In contrast, immobilizing CCL21 on Au surfaces 
(Figs. 5B and S6B) resulted in significant changes for the proliferation 
and expansion indexes. Specifically, the median values for the expansion 
index were of 1.10 and 1.16 for the concentrations of 20 ng/ml and 1 
ng/ml respectively, showing an improvement of 10% and 16% in 
comparison with the positive control. Similarly, the proliferation index 
increased to 1.06 and 1.08 for each concentration. The replication index 
also showed a slight increase with median values of 1.06 for 20 ng/ml 
and 1.10 for 1 ng/ml. 
2.2.2. Effect of 3D PEG-Hep hydrogels on CD4+ T cell proliferation 
As mentioned above, the 3%wt PEG-Hep hydrogels were selected to 
culture CD4+ T cells activated with Dynabeads, which enabled cell 
infiltration and thus a truly 3D culture (Figs. 3C and S4). Moreover, a 
propidium iodide (PI) viability test was performed, which showed more 
non-viable or apoptotic PI+ cells in suspension cultures (positive control; 
31%) than when 3%wt hydrogels were used (15%) through flow 
cytometry (Fig. 6A and B). CD4+ T cell proliferation was then assessed 
through the expansion, replication, and proliferation indexes obtained 
from CFSE diagrams (Fig. 6C) also through flow cytometry. 
First, unloaded 3%wt PEG-Hep hydrogels were used as a scaffold to 
study CD4+ T cell proliferation on day 5 (Figs. 6D and S7). The median 
normalized replication index obtained in these 3%wt PEG-Hep hydro-
gels was 1.25, i.e. an improvement of a 25% was achieved, whereas the 
expansion and proliferation indexes showed medians of 1.10 and 1.05, 
respectively. All three parameters showed statistically significant in-
creases compared to the positive controls. The most significant 
improvement was observed for the replication index, which indicates 
that the responding cells that get activated in the synthetic hydrogels 
proliferate more than the activated cells in suspension. 
Fig. 7. Effect of CCL21-loaded 3D PEG-Hep hydrogels on CD4þ T cell proliferation and differentiation. A) Normalized proliferation analysis of CD4+ T cells 
stimulated with Dynabeads 6 days after seeding in 3 wt% PEG-Hep hydrogels loaded with 100 ng/ml of CCL21 (Ndonors = 6). B) Percentage of naïve (TN), central 
memory (TCM), and effector memory (TEM) CD4+ T cells on day 5 (Ndonors = 6). The negative control consists of cells seeded in suspension without Dynabeads, 
whereas in the positive control, cells are seeded with Dynabeads. When cells are seeded in the hydrogels, they are always stimulated with Dynabeads. Statistical 
significance was determined by the Mann-Whitney U test (*p < 0.05, **p < 0.01). 
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2.2.3. Effect of CCL21-loaded 3D PEG-Hep hydrogels on CD4+ T cell 
proliferation and differentiation 
Hydrogels were finally loaded with different concentrations of 
CCL21 and 100 ng/ml was identified as the one resulting in the highest 
expansion indexes (Figs. S8 and 7A). The difference between this result 
and the values obtained with the CCL21-immobilized surfaces (Fig. 7B) 
are, most probably, due to the increased dimensionality when moving 
from 2D to 3D biomaterials. In this case, a 29% increase of the repli-
cation index on day 6 was obtained in comparison with the positive 
control. The proliferation and expansion indexes showed less pro-
nounced increases with average values of 1.05 and 1.06, respectively. 
Although not statistically significant, we observed slight decreases in the 
expansion and replication indexes without cytokine loading, which ev-
idence the importance of the timings when extrapolating the results to 
the clinics. 
To determine the phenotype of the CD4+ T cells after proliferation, 
differentiation assays were performed 5 days after seeding (Figs. 7B and 
S9), given its importance in the clinical outcomes obtained in ACT [16, 
74]. Specifically, naïve (TN; CD45RO− /CD62L+), central memory (TCM; 
CD45RO+/CD62L+), and effector memory (TEM; CD45RO+/CD62L− ) 
cells were identified by flow cytometry [67]. The percentages of CD4+ T 
cells that express CD45RO and CD62L prior to stimulation (negative 
control) are affected by intrinsic donor variability. As expected, they 
mainly showed a TN phenotype with a median value of 53%, whereas the 
TEM and TCM phenotypes were found in smaller percentages, 12% and 
32%, respectively. After stimulation, the median value of TN cells 
decreased to 4% in suspension (positive control). Both unloaded and 
loaded (100 ng/ml of CCL21) hydrogels also exhibited a decrease of this 
phenotype with median values of 14% and 11% respectively, although it 
is more preserved than in the suspension cells. Consequently, the TEM 
and TCM phenotypes increased in comparison with the negative control. 
Specifically, the median values for the TCM phenotype of the positive 
control, unloaded and loaded hydrogels were 68%, 51%, and 47%, 
respectively, thus expressing lower percentages when using hydrogels. 
For the TEM phenotype, median values rose to 26% for T cells in sus-
pension, 21% for unloaded hydrogels, and 33% for hydrogels with 100 
ng/ml of CCL21. Thus, the cytokine loaded hydrogels promoted an 
increased proportion of effector cells. These results point out that 
PEG-Hep hydrogels can be used to modify the resulting phenotype of T 
cells and the use of different chemical stimuli is a promising strategy to 
achieve diverse differentiation pathways. 
Thus, the fabrication of an artificial matrix capable of mimicking the 
ECM of SLOs is expected to be a powerful approach to promote immune 
cell expansion as well as preserve and augment T cell cytotoxicity to-
wards cancer cells [21,22,51]. The use of these matrices in cellular 
immunotherapies, which require the removal and culture of T cells ex 
vivo to expand them several thousand-fold, could be useful towards 
overcoming current limitations [8,75]. The 3D PEG-Hep hydrogels here 
employed showed an interconnected porous structure with adequate 
rheological properties to mimic the physical structure of the LNs [61–63, 
76], and favor CD4+ T cell migration through the matrix [51]. More-
over, the capacity of the hydrogels to retain positively charged mole-
cules has been shown, opening the way to introduce other biomolecules, 
such as adhesion molecules (e.g. ICAM-1), which could improve the 
mimicking and understanding of the ECM of the LNs and its interaction 
with cells [56,77,78]. These tunable characteristics should provide ad-
vantages compared to the current commercial platforms, such as 3D 
polystyrene scaffolds and Matrigel, which showed intrinsic limitations 
as they were not designed for this purpose [20]. Additionally, the 
hydrogels here proposed are an excellent system to distinguish the ef-
fects of the LNs from the APCs, which we mimicked with Dynabeads. In 
contrast, a recently reported interesting system based on PEG hydrogels 
combined with hyaluronic acid to mimic the lymphoid tissue was 
functionalized with antiCD3 and antiCD28, thus also providing APC 
signals [79]. Moreover, our hydrogels contain heparin, as a derivate of 
the heparan sulfate groups that cover the lymphoid tissues and serve as 
anchoring for relevant molecules [23,24]. Nevertheless, the unloaded 
hydrogels already resulted in an improvement of CD4+ T cell prolifer-
ation and changes in the resulting phenotypes, demonstrating the ben-
efits of the physical characteristics of the 3D PEG-Hep scaffolds. The 
addition of CCL21, which showed better results immobilized than in 
suspension, enhanced CD4+ T cell proliferation and accentuated the 
differences in the phenotypes. These results show the potential that 3D 
PEG-Hep hydrogels hold as a platform for T cell culture, which could be 
further improved by adding other chemical molecules, such as CCL19 
and ICAM-1, to maximize successful clinical outcomes [80–83]. More-
over, the characteristics of these hydrogels make them suitable for 
complementary applications such 3D (bio)printing or in vivo local de-
livery of pre-activated T cells, similar to other materials [84]. All these 
options will be evaluated in the future along with in vitro experiments 
not only with CD4+ T cells, but also with other medically relevant 
phenotypes such as CD8+ and regulatory T cells. 
3. Conclusions 
In conclusion, CCL21-loaded 3D PEG-Hep hydrogels were synthe-
sized, characterized, and used for CD4+ T cell culturing. This scaffold 
provides an improvement in cell proliferation and an influence on the 
phenotype, which could be further explored towards the fabrication of 
artificial LNs. These engineered organs are expected to help surpassing 
the limitations of current immunotherapies such as producing large 
amounts of T cells with therapeutic phenotypes. Moreover, the CCL21- 
loaded 3D PEG-Hep hydrogels are expected to be compatible with 
perfusion systems and novel bioreactors to work under good 
manufacturing practice (GMP) conditions in large facilities. 
4. Materials and methods 
Materials: The mGFP was produced and purified as described else-
where [85]. LMWH was purchased from Fisher Scientific (Fisher Bio-
Reagents, Spain). The CD4+ T cell isolation kit was acquired from 
Miltenyi Biotec GmbH (Germany). NuncTM Lab-TekTM chambers, fetal 
bovine serum (FBS), penicillin/streptomycin (P/S), CellTrace CFSE cell 
proliferation kit, and Dynabeads were provided by Thermo Fisher Sci-
entific (USA). The anti-human CD3 FITC, CD4 PE, CD45RO FITC anti-
bodies and their controls used for flow cytometry were acquired from 
Immunotools GmbH (Germany), whereas CD62L PE and its control were 
bought from BioLegend (USA). Lymphoprep was obtained from Stemcell 
Technologies (Canada). PEG-SH (Mn 10,000 g/mol), N-(2-aminoethyl) 
maleimide trifluoroacetate salt (AEM), 1-hydroxybenzotriazole hydrate 
(HOBT), N-(3-dimethylamino-propyl)-N′-ethylcarbodiimide hydrochlo-
ride (EDC⋅HCl), 2-(N-morpholino) ethanesulfonic acid (MES), exodus-2 
(CCL21) human, Dulbecco’s PBS, RPMI-1640 media, and the rest of the 
products not otherwise specified were purchased from Sigma-Aldrich 
(USA). 
Synthesis and optimization of LMWH functionalized with maleimide: The 
functionalization of LMWH with maleimide was based in a method 
previously described [86,87]. For 100 mg of LMWH dissolved in a so-
lution of 0.1 M MES, 20.6 mg of HOBT, 20.6 mg of AEM, and 20.6 mg of 
EDC⋅HCl were used (Fig. S1). To maximize the yield, the reaction was 
left overnight. The product was purified by dialysis (MWCO 1000) 
against 500 ml of deionized water for 6–15 h during the first step, and 
500 ml of MilliQ water during the second and last steps. Once the 
product was purified, it was lyophilized and characterized by 1H NMR 
and ATR (Fig. S2). 1H NMR (250 MHz, H2O-d2, δ): 6.83 ppm (s, 2H, 
CH–CH); ATR: ν = 1709 (C–O), 1564 (CH–CH) cm− 1. 
PEG-Hep hydrogel formation: A solution of PEG-SH was mixed with a 
solution of the functionalized Mal-LMWH in a 1:1.5 ratio, both in PBS. 
For such ratio, five maleimide groups per molecule of heparin were 
estimated to react with the four thiol groups of PEG [87]. Different 
concentrations in weight of PEG were used (6%wt, 4%wt, and 3%wt) to 
obtain different types of PEG-Hep hydrogels. Once the solutions were 
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mixed, they were kept in an incubator at 37◦C during at least 2 h to 
become a hydrogel. Negative controls consisting of solutions of only one 
of the reactants as well as a mixture of non-functionalized LMWH and 
PEG-SH at relevant concentrations confirmed that hydrogel formation is 
caused by the reaction between the thiol groups of the 4-arm PEG and 
the maleimide-functionalized LMWH (Fig. S3). 
Swelling ratio: The swelling ratio of the 3%wt PEG-Hep hydrogels was 
determined in PBS using the formula Ws/Wd, where Ws and Wd are the 
weight of the swollen and dry hydrogel, respectively (Nsamples = 3). 
Scanning electron microscopy (SEM): Although this technique is typi-
cally used in dry samples, a special protocol at the vacuum chamber was 
used, which enabled to image the structure of the hydrated hydrogels. 
Thus, the structure of hydrogels with different compositions (6%wt, 4% 
wt, and 3%wt of PEG) was observed. The equipment used was a FEI 
Quanta 650F Environmental scanning electron microscope (Thermo 
Fisher Scientific, USA). 
X-ray microtomography: A Skyscan 1272 high-resolution micro 
computed tomography (Bruker, USA) was used to study the 3D structure 
of the hydrogels and analyze the porosity and interconnectivity of the 
pores. Samples stored in PBS were frozen with liquid nitrogen and then 
lyophilized to be scanned. The size of the measured samples was 2 mm in 
height and 1 cm in diameter. The scanning time was 3 h with a minimum 
resolution of 5 μm. 
Confocal microscopy: The images were obtained with a Leica TCS SP5 
confocal microscope (Leica, Germany) equipped with 10X and 63X ob-
jectives on day 5. 
Dynamic Light Scattering (DLS) and zeta potential: Solutions of LMWH 
(8.9 μM), mGFP (27.0 μM), and a mixture of mGFP (27.0 μM) with 
0.045 mg of LMWH, were prepared in PBS. The solution of PBS was also 
measured as a control. All samples were passed through a filter (0.22 
μm) and vortexed before measurements. 1 ml of each resulting suspen-
sion was measured at least three times with three single runs per mea-
surement at 25◦C using a Zetasizer Nano ZS (Malvern Panalytical Ltd, 
UK). 
Loading capacity of the hydrogels: To demonstrate the ability of PEG- 
Hep hydrogels to attract positively charged molecules to their nega-
tively charged LMWH, different concentrations of mGFP were incubated 
with the hydrogels during 1 h. After that, the supernatant was removed 
and the hydrogels were washed three times with PBS. The fluorescence 
of the hydrogels was measured with a Victor 3 Multioption plate reader 
(Perkin Elmer, Inc., USA). 
Rheology measurements: The SAOS technique was used to characterize 
the mechanical properties of the hydrogels. It consists of a small- 
amplitude torsional oscillation that generates a shear flow in the sam-
ple and requires a trial-and-error approach to find the appropriate 
values of strain and frequency for each gel [50]. The experiments per-
formed were strain sweeps, frequency sweeps, and time sweeps at 37◦C 
to calibrate the range of pressure and frequency where the hydrogels 
maintain their viscoelastic behavior, characterize the gelification pro-
cesses, and obtain the Ge value of the gels. Thus, the G′ and loss modulus 
(G′′) in the linear-viscoelastic regime (LVE) of the hydrogels were 
measured. The equipment used was a Rheometer HAAKE RheoStress 
RS600 (Thermo Electron Corporation, USA) with a 10 mm diameter 
rotor. 
Preparation of Au surfaces to immobilize CCL21: The function of CCL21 
and its effect on T cell proliferation was studied in suspension and 
immobilized on Au surfaces to analyze the influence of fixing this 
cytokine on CD4+ T cell proliferation. To prepare the Au samples, glass 
slides were thoroughly washed with piranha solution and coated with 3 
nm of titanium and 10 nm of Au in an evaporation System Auto 306 (Boc 
Edwards, UK). The resulting Au surfaces were fixed to the bottom of 8- 
well Lab-Tek chambers with picodent twinsil speed glue (Picodent, 
Germany). Then, CCL21 was incubated during 1 h at the desired con-
centration and the supernatant was subsequently removed. Finally, cells 
were seeded on the substrates. To prove the success of the surface 
functionalization strategy, an immunostaining was performed (Fig. S5). 
CD4+ T cell culture in PEG-Hep hydrogels: Primary human CD4+T cells 
of healthy adult donors were obtained from buffy coats provided by 
“Banc de Sang i Teixits” (Barcelona, Spain) after the approval of the 
research project by the “Ethics Committee on Animal and Human 
Experimentation” of the Autonomous University of Barcelona (Nr. 3511) 
following an established protocol [11,12]. Briefly, it consists of isolating 
peripheral blood mononuclear cells (PBMCs) by density gradient 
centrifugation using Ficoll and then extracting the CD4+ T cells with a 
commercial CD4+ T cell isolation kit. The purity of the cells was 
measured by flow cytometry with the antibodies anti-human CD3 FITC, 
anti-human CD4 PE, and the negative controls. Only samples that were 
at least 90% positive for both CD3+ and CD4+ (usually CD3+CD4+ T 
cells > 95%) were used. Afterwards the cells were kept in RPMI medium 
with 10% FBS and 1% P/S in the incubator at 37◦C overnight. Similarly, 
3%wt PEG-Hep hydrogels were also incubated overnight in PBS to 
achieve complete swelling. On the next day, the resulting hydrogels 
were placed in 96-well plates and CD4+ T cells (106 cells/ml) and 
Dynabeads (1:1 ratio) in the supplemented RPMI medium were seeded 
on them, given that the pore size and interconnectivity of the hydrogels 
ensures their proper infiltration through the structure. For the 
CCL21-loaded hydrogels, 100 μl of the chosen CCL21 solution were 
incubated during 1 h, after which the supernatant was removed, prior to 
cell seeding. 
Propidium iodide (PI) viability test: CD4+ T cells were stained with 0.5 
μl of propidium iodide (1 mg/ml, Sigma-Aldrich) during 3 min at room 
temperature before the flow cytometry measurements. 
CD4+ T cell proliferation and differentiation in PEG-Hep hydrogels: 
CD4+ T cells used for proliferation analysis were stained before seeding 
with a CFSE cell proliferation kit following the instructions of the 
manufacturer. They were analyzed by flow cytometry on day 6 after 
mechanically destroying the hydrogels through pipetting to recover the 
cells. The results obtained were normalized to the positive control of 
each donor, which was assigned a value of 1, to reduce the intrinsic 
donor variability. Raw data can be seen in the supplementary data 
(Figs. S6 and S7). For the differentiation analysis, CD4+ T cells were 
extracted from the hydrogels as described above and analyzed 5 days 
after seeding. Cells were stained with anti-human CD45 RO FITC, CD62L 
PE, and the corresponding negative controls for 30 min at 0◦C. After-
wards, they were washed and analyzed by flow cytometry with a BD 
FACSCanto (BD Bioscience, USA). 
Data treatment: The microscope images were treated with FiJi 
(ImageJ, USA), the flow cytometry data was analyzed with FlowJo 
(FlowJo LLC, USA), the graphs and statistical tests were performed in 
Origin (OriginLab Corporation, USA). The boxes of the box plots 
correspond to the interquartile range defined by the 25th and 75th 
percentiles, the central line is the median, the whiskers show one stan-
dard deviation, – represents the maximum and minimum, and □ is the 
average. 
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[20] E. Pérez del Río, M. Martinez Miguel, J. Veciana, I. Ratera, J. Guasch, Artificial 3D 
culture systems for T cell expansion, ACS Omega 3 (2018) 5273–5280, https://doi. 
org/10.1021/acsomega.8b00521. 
[21] J.E. Gretz, A.O. Anderson, S. Shaw, Cords, channels, corridors and conduits: critical 
architectural elements facilitating cell interactions in the lymph node cortex, 
Immunol. Rev. 156 (1997) 11–24, https://doi.org/10.1111/j.1600-065X.1997. 
tb00955.x. 
[22] T. Katakai, T. Hara, J.-H. Lee, H. Gonda, M. Sugai, A. Shimizu, A novel reticular 
stromal structure in lymph node cortex: an immuno-platform for interactions 
among dendritic cells, T cells and B cells, Int. Immunol. 16 (2004) 1133–1142, 
https://doi.org/10.1093/intimm/dxh113. 
[23] K. Uchimura, M. Morimoto-Tomita, A. Bistrup, J. Li, M. Lyon, J. Gallagher, 
Z. Werb, S.D. Rosen, HSulf-2, an extracellular endoglucosamine-6-sulfatase, 
selectively mobilizes heparin-bound growth factors and chemokines: effects on 
VEGF, FGF-1, and SDF-1, BMC Biochem. 7 (2006) 1–13, https://doi.org/10.1186/ 
1471-2091-7-2. 
[24] X. Yin, J. Truty, R. Lawrence, S.C. Johns, R.S. Srinivasan, T.M. Handel, M. 
M. Fuster, A critical role for lymphatic endothelial heparan sulfate in lymph node 
metastasis, Mol. Canc. 9 (2010) 1–20, https://doi.org/10.1186/1476-4598-9-316. 
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E. Pérez del Río et al.                                                                                                                                                                                                                          
Biomaterials 259 (2020) 120313
12
[33] S.J. Bryant, K.S. Anseth, Hydrogel properties influence ECM production by 
chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels, J. Biomed. 
Mater. Res. 59 (2002) 63–72, https://doi.org/10.1002/jbm.1217. 
[34] M.W. Tibbitt, K.S. Anseth, Hydrogels as extracellular matrix mimics for 3D cell 
culture, Biotechnol. Bioeng. 103 (2009) 655–663, https://doi.org/10.1002/ 
bit.22361. 
[35] J. Guasch, J. Diemer, H. Riahinezhad, S. Neubauer, H. Kessler, J.P. Spatz, Synthesis 
of binary nanopatterns on hydrogels for initiating cellular responses, Chem. Mater. 
28 (2016) 1806–1815, https://doi.org/10.1021/acs.chemmater.5b04910. 
[36] J. Zhu, Bioactive modification of poly(ethylene glycol) hydrogels for tissue 
engineering, Biomaterials 31 (2010) 4639–4656, https://doi.org/10.1016/j. 
biomaterials.2010.02.044. 
[37] H. Wang, L. Cai, A. Paul, A. Enejder, S.C. Heilshorn, Hybrid elastin-like 
polypeptide–polyethylene glycol (ELP-PEG) hydrogels with improved transparency 
and independent control of matrix mechanics and cell ligand density, 
Biomacromolecules 15 (2014) 3421–3428, https://doi.org/10.1021/bm500969d. 
[38] M.C. Cushing, K.S. Anseth, Hydrogel cell cultures, Science 316 (2007) 1133–1134, 
https://doi.org/10.1126/science.1140171. 
[39] C.T. Huynh, F. Liu, Y. Cheng, K.A. Coughlin, E. Alsberg, Thiol-epoxy “click” 
chemistry to engineer cytocompatible PEG-based hydrogel for siRNA-mediated 
osteogenesis of hMSCs, ACS Appl. Mater. Interfaces 10 (2018) 25936–25942, 
https://doi.org/10.1021/acsami.8b07167. 
[40] S.J. Paluck, T.H. Nguyen, H.D. Maynard, Heparin-mimicking polymers: synthesis 
and biological applications, Biomacromolecules 17 (2016) 3417–3440, https://doi. 
org/10.1021/acs.biomac.6b01147. 
[41] B. Mulloy, J. Hogwood, E. Gray, R. Lever, C.P. Page, Pharmacology of heparin and 
related drugs, Pharmacol. Rev. 68 (2016) 76–141, https://doi.org/10.1124/ 
pr.115.011247. 
[42] T. Yang, A. Hussain, S. Bai, I.A. Khalil, H. Harashima, F. Ahsan, Positively charged 
polyethylenimines enhance nasal absorption of the negatively charged drug, low 
molecular weight heparin, J. Contr. Release 115 (2006) 289–297, https://doi.org/ 
10.1016/j.jconrel.2006.08.015. 
[43] M.C.Z. Meneghetti, A.J. Hughes, T.R. Rudd, H.B. Nader, A.K. Powell, E.A. Yates, M. 
A. Lima, Heparan sulfate and heparin interactions with proteins, J. R. Soc. Interface 
12 (2015) 20150589, https://doi.org/10.1098/rsif.2015.0589. 
[44] G.J. Merli, J.B. Groce, Pharmacological and clinical differences between low- 
molecular-weight heparins: implications for prescribing practice and therapeutic 
interchange, P T 35 (2010) 95–105. https://pubmed.ncbi.nlm.nih.gov/20221326/. 
[45] R. Sasisekharan, K. Viswanathan, Functional glycomics and the future of glycomic 
drugs, in: S. Ekins, J.J. Xu (Eds.), Drug Efficacy, Safety, and Biologics Discovery, 
John Wiley & Sons, Inc., New Jersey, USA, 2008, pp. 277–300. 
[46] K. Chandarajoti, J. Liu, R. Pawlinski, The design and synthesis of new synthetic 
low-molecular-weight heparins, J. Thromb. Haemostasis 14 (2016) 1135–1145, 
https://doi.org/10.1111/jth.13312. 
[47] A.D. Baldwin, K.G. Robinson, J.L. Militar, C.D. Derby, K.L. Kiick, R.E. Akins Jr., In 
situ crosslinkable heparin-containing poly(ethylene glycol) hydrogels for sustained 
anticoagulant release, J. Biomed. Mater. Res. Part A 100A (2012) 2106–2118, 
https://doi.org/10.1002/jbm.a.34050. 
[48] A.D. Baldwin, K.L. Kiick, Reversible maleimide–thiol adducts yield glutathione- 
sensitive poly(ethylene glycol)–heparin hydrogels, Polym. Chem. 4 (2013) 
133–143, https://doi.org/10.1039/C2PY20576A. 
[49] N. Davydova, X.R. Rodriguez, C. Blázquez, A. Gómez, I. Perevyazko, J. Guasch, 
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